Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical setting

Journal of Immunological Methods

Volumn 407, Issue , 2014, Pages 9-14

  Fhied, Cristina ^a   Kanangat, Sivadasan ^a   Borgia, Jeffrey A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Analytical validation; Assay; Chronic kidney allograft rejection; Development; Luminex; Vimentin

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN AUTOANTIBODY;

ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; IMMUNOBEAD ASSAY; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STORAGE; TASK PERFORMANCE; VALIDATION STUDY;

ANALYTICAL VALIDATION; ASSAY; CHRONIC KIDNEY ALLOGRAFT REJECTION; DEVELOPMENT; LUMINEX; VIMENTIN;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEASIBILITY STUDIES; GRAFT REJECTION; HUMANS; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MICROSPHERES; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; VIMENTIN;

EID: 84901465725     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.03.011     Document Type: Article

References (21)

1. Bilalic S., Michlmayr A., Gruber V., Buchberger E., Burghuber C., Bohmig G.A., Oehler R. Lymphocyte activation induces cell surface expression of an immunogenic vimentin isoform. Transpl. Immunol. 2012, 27:101-106.
2. Boilard E., Bourgoin S.G., Bernatchez C., Surette M.E. Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2. Blood 2003, 102:2901-2909.
3. Chapman J.R., O'Connell P.J., Nankivell B.J. Chronic renal allograft dysfunction. J. Am. Soc. Nephrol. 2005, 16:3015-3026.
4. Churchman S.M., Geiler J., Parmar R., Horner E.A., Church L.D., Emery P., Buch M.H., McDermott M.F., Ponchel F. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor. Clin. Exp. Rheumatol. 2012, 30:534-542.
5. Dragun D., Philippe A., Catar R. Role of non-HLA antibodies in organ transplantation. Curr. Opin. Organ Transplant. 2012, 17:440-445.
6. Farlow E.C., Patel K., Basu S., Lee B.S., Kim A.W., Coon J.S., Faber L.P., Bonomi P., Liptay M.J., Borgia J.A. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin. Cancer Res. 2010, 16:3452-3462.
7. Gomara M.J., Haro I. Citrullinated peptides in the diagnosis of rheumatoid arthritis. Curr. Top. Med. Chem. 2013, 13:743-751.
8. Grabias B.M., Konstantopoulos K. Epithelial-mesenchymal transition and fibrosis are mutually exclusive responses in shear-activated proximal tubular epithelial cells. FASEB J. 2012, 26:4131-4141.
9. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
10. Keuschnigg J., Henttinen T., Auvinen K., Karikoski M., Salmi M., Jalkanen S. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 2009, 114:478-484.
11. Kuna A.T. Mutated citrullinated vimentin antibodies in rheumatoid arthritis. Clin. Chim. Acta 2012, 413:66-73.
12. Li H.X., Fan Q.H., Zhang Z.H., Zhang W.M., Fan X.S., Song G.X. Clinicopathologic analysis of epithelioid sarcoma-like hemangioendothelioma. Zhonghua Bing Li Xue Za Zhi 2012, 41:767-768.
13. Moisan E., Girard D. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J. Leukoc. Biol. 2006, 79:489-498.
14. Monaco A.P., Burke J.F., Ferguson R.M., Halloran P.F., Kahan B.D., Light J.A., Matas A.J., Solez K. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am. J. Kidney Dis. 1999, 33:150-160.
15. Nieminen M., Henttinen T., Merinen M., Marttila-Ichihara F., Eriksson J.E., Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell Biol. 2006, 8:156-162.
16. Patel K., Farlow E.C., Kim A.W., Lee B.S., Basu S., Coon J.S., DeCresce D., Thimothy L., Walters K.A., Fhied C., Chang C., Chen S.H., Faber L.P., Bonomi P., Liptay M.J., Borgia J.A. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Int. J. Cancer 2010, 129:133-142.
17. Rose M.L. Role of anti-vimentin antibodies in allograft rejection. Hum. Immunol. 2013, 74:1459-1462.
18. Tan P.H., Cheng L., Rioux-Leclercq N., Merino M.J., Netto G., Reuter V.E., Shen S.S., Grignon D.J., Montironi R., Egevad L., Srigley J.R., Delahunt B., Moch H. Renal tumors: diagnostic and prognostic biomarkers. Am. J. Surg. Pathol. 2013, 37:1518-1531.
19. Todd D.J., Knowlton N., Amato M., Frank M.B., Schur P.H., Izmailova E.S., Roubenoff R., Shadick N.A., Weinblatt M.E., Centola M., Lee D.M. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum. 2011, 63:894-903.
20. Xu B., deWaal R.M., Mor-Vaknin N., Hibbard C., Markovitz D.M., Kahn M.L. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell. Biol. 2004, 24:9198-9206.
21. Yakupoglu U., Baranowska-Daca E., Rosen D., Barrios R., Suki W.N., Truong L.D. Post-transplant nephrotic syndrome: a comprehensive clinicopathologic study. Kidney Int. 2004, 65:2360-2370.